Online Only Articles

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Hematology, Uppsala University Hospital, Sweden
Institute of Applied Biosciences, Thessaloniki, Greece
Institute of Applied Biosciences, Thessaloniki, Greece
Institute of Applied Biosciences, Thessaloniki, Greece;Università Vita-Salute San Raffaele, Milan, Italy;Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Università Vita-Salute San Raffaele, Milan, Italy;Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK
The Feinstein Institute for Medical Research, Northwell Health, New York, USA
CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic;University Hospital Brno, Czech Republic
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
First Department of Propaedeutic Medicine, University of Athens, Greece
The Feinstein Institute for Medical Research, Northwell Health, New York, USA
Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden
IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d’ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France
First Department of Propaedeutic Medicine, University of Athens, Greece
Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Sweden
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, Laboratoire d’ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France
Department of Medicine, Hematology and Clinical Immunology Branch, Padova University School of Medicine, Italy;Venetian Institute of Molecular Medicine, Padova, Italy
Department of Hemato-Oncology, Belfast City Hospital, Belfast, UK
Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy
Department of Hematology, Rigshospitalet, Copenhagen, Denmark
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands
CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic;University Hospital Brno, Czech Republic
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
The Feinstein Institute for Medical Research, Northwell Health, New York, USA
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK
Department of Immunology, Mayo Clinic, Rochester, MV, USA
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA
CEITEC-Central European Institute of Technology, MasarykBrno, Czech Republic
Hematology Department, Nikea General Hospital, Piraeus, Greece
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France
Università Vita-Salute San Raffaele, Milan, Italy;Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, Thessaloniki, Greece;Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Vol. 103 No. 4 (2018): April, 2018 https://doi.org/10.3324/haematol.2017.182634